Insertion/deletion polymorphism in the BRCA2 nuclear localization signal

Biomedical Research

Volumn 26, Issue 3, 2005, Pages 109-116

  Yoshikawa, Yasunaga ^a,b   Morimatsu, Masami ^b   Ochiai, Kazuhiko ^a,c   Nagano, Masashi ^d   Yamane, Yoshihisa ^e   Tomizawa, Nobuyuki ^a   Sasaki, Nobuo ^f   Hashizume, Kazuyoshi ^a  

^a IWATE UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; RAD51 PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA POLYMORPHISM; DOG; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ALLELES; ANIMALS; BRCA2 PROTEIN; DOGS; GENE FREQUENCY; NUCLEAR LOCALIZATION SIGNALS; POLYMORPHISM, GENETIC;

CANIS FAMILIARIS;

EID: 27244435061     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.26.109     Document Type: Article

References (35)

1. Arai M, Utsunomiya J and Miki Y (2004) Familial breast And ovarian cancers. Int J Clin Oncol 9, 270-282.
2. Balmain A (2002) Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108. 145-152.
3. Boulikas T (1994) Putative nuclear localization signals (NLS) in protein transcription Factors. J Cell Biochem 55. 32-58.
4. Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZD and Lee WH (1998) The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 95, 5287-5292.
5. Cokol M, Nair R and Rost B (2000) Finding nuclear localization signals; EMBO Rep 1, 411-415.
6. Davies AA, Masson JY. Mcllwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR and West SC (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 7, 273-282.
7. Dingwall C and Laskey RA (1991) Nuclear targeting sequences-a consensus? Trends Biochem Sci 16, 478-481.
8. Esashi F, Christ N. Gannon J, Liu Y, Hunt T. Jasin M and West SC (2005) CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434, 598-604.
9. Fabbro, M and Henderson BR (2003) Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282 59-69.
10. Garvin AM, Attenhofer-Haner M and Scott RJ (1997) BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. J Med Genet 34, 990-995.
11. Hakansson S. Johannsson O, Johansson U. Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N. Kristoffersson U, Olsson H and Borg A (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60, 1068-1078.
12. Hodel MR, Corbett AH and Hodel AE (2001) Dissection of a nuclear localization signal. J Biol Chem 276, 1317-1325.
13. Kirkness EF, Bafna V, I Halpern AL, Levy S, Remington K. Rusch DB, Delcher AL, Pop M. Wang W, Fraser CM and Venter JC (2003) The dog genome: survey sequencing and comparative analysis. Science 301, 1898-1903.
14. Lee S, Neumann M, Stearman R, Stauber R, Pause A. Pavlakis GN and Klausner RD (1999) Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 19, 1486-1497.
15. Lo T, Pellegrini L. Venkitaraman AR and Blundell TL (2003) Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair And cancer, DNA Repair (Amst) 2. 1015-1028.
16. Mizuta R, LaSalle JM, Cheng HL, Shinohara A, Ogawa H. Copeland N, Jenkins NA. Lalande M and Alt FW (1997) RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc Natl Acad Sci USA 94, 6927-6932.
17. Moriniatsu M, Donoho G and Hasty P (1998) Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res 58, 3441-3447.
18. Moynahan ME (2002) The cancer connection BRCA1 and BRCA2 tumor suppression in mice and human. Oncogene 21, 8994-9007.
19. Nerurkar VR, Chitale AR, Jalnapurkar BV, Naik SN and Lalitha VS (1989) Comparative pathology of canine mammary tumours. J Comp Pathol 101, 389-397.
20. Ochiai K, Morimatsu M, Tomizawa N Syuto (2001) Cloning and sequencing full length canine Brca2 and Rad5l cDNA. J Vet Med Sci 63, 1103-1108.
21. Ochiai K. Morimatsu M, Yushikawa Y, Syuto B and Hashizume K (2004) Brca2 C-terminus interracts with Rad51 and contributes to nuclear focus formation in double-strand break repair of DNA. Biomed Res 25, 269-275.
22. Parker HG. Kim LV, Sutter NB, Carlson S, Lorentzen TD, Malek TB, Johnson GS, DeFrance HB, Ostrander EA and Kruglyak L (2004) Genetic structure of the purebred domestic dog. Science 304, 1160-1164.
23. Priester WA and Mantel N (1971) Occurrence of tumors in domestic animals, Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 47, 1333-1344.
24. Rosol TJ. Tannehill-Gregg SH, LeRoy BE, Mandl S and Contag CH (2003) Animal models of bone metastasis. Cancer 97, 748-757.
25. Rutteman GR, Cornelisse CJ, Dijkshoorn NJ, Poortman J and Misdorp W (1988) Flow cytometric analysis of DNA ploidy in canine mammary tumors. Cancer Res 48, 3411-3417.
26. Sarkisian CJ, Master SR, Huber LJ, Ha SI and Chodosh LA (2001) Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals. J Biol Chem 276. 37640-37648.
27. Scully R and Livingston DM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432.
28. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P and Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated, by Rad51 in mice lacking Brca2. Nature 386, 804-810.
29. Shin DS. Pellegrini L, Daniels DS, Yelent B, Craig L, Bates D, Yu DS, Shivji MK, Hitomi C, Arvai AS, Volkmann N, Tsuruta H, Blundell TL, Venkitaraman AR and Tainer JA (2003) Full-length archaeal-Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2. EMBO J 22, 4566-4576.
30. Spain BH, Larson CJ, Shihabuddin LS, Gage FH and Verma IM (1999) Truncated BRCA2 is cytoplasmic: implications For cancer-linked mutations. Proc Natl Acad Sci USA 96, 13920-13925.
31. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182.
32. Wayne RK and Vila C (2001) Phylogeny and origin of the domestic dog. In: The Genetics of the Dog (Ruvinsky A, Sampson J, eds.), pp 1-13, CABI Publishing Inc., Oxon.
33. Yang H, Li Q, Fan J, Holloman WK and Pavletich NP (2005) The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature 433, 653-657.
34. Yano K, Morotomi K, Saito H, Kato M, Matsuo F and Miki Y (2000) Nuclear localization signals of the BRCA2 protein. Biochem Biophys Res Commun 270, 171-175.
35. Yu DS, Sonoda E, Takeda S, Huang CL, Pellegrini L, Blundell TL and Venkitaraman AR (2003) Dynamic control of Rad5l combinase by self-association and interaction with BRCA2. Mol Cell 12, 1029-1041.